Marken The Preferred Partner To Fight Zika Virus

Pharma Industry Turns to Marken as a Trusted Logistics Partner

Research Triangle Park, North Carolina, February 5, 2016 – Marken announced today they are working with key pharma partners in the race to find a vaccine and treatment for the Zika virus, declared as a public health emergency by the World Health Organization (WHO) earlier this week.

Marken is frequently chosen to handle dangerous materials in crises conditions in remote locations.  Because of their capabilities in Africa, Marken was selected as a key logistics provider during the Ebola outbreak. Marken was also selected during the MERS* outbreak as the only provider entrusted to deliver clinical trial materials directly to patients in their homes in South Korea, which enabled their clinical trials to continue.

Wes Wheeler, Chief Executive Officer, commented on the current situation: “We are proud to again be chosen as a trusted partner by our clients to work together against the Zika virus. Our history of delivery in Latin America, especially in difficult circumstances, makes us the first choice by the pharmaceutical companies which are working very hard to develop new vaccines. We will put our five Clinical Supply Centers to work in Latin America, if necessary, to help distribute new vaccines to the region.  We will work with government agencies and customs officials to clear hurdles and generally do what it takes to help fight this outbreak.”

*Middle Eastern Respiratory Syndrome (MERS)

About Marken

Marken is the only patient-centric supply chain organization 100% dedicated to the pharmaceutical and life sciences industries. Marken maintains the leading position for Direct to Patient services and biological sample shipments, and offers a state of the art GMP-compliant Clinical Supply Center network and logistic hubs in 43 locations worldwide. Marken’s 630 staff members manage 50,000 drug and biological shipments every month at all temperature ranges in more than 150 countries.  Additional services such as biological kit production, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken’s unique position in the pharma and logistics industry.

CONTACT: Christine Noble,, +1 919 474 6890,

Back to Index